For GPs

Designed to show whether important work is being finished.

Partners carry the responsibility for work they cannot personally see. Reedley is designed to make that work visible — the evidence behind every item, a named owner, and evidence of what actually happened — with every clinical decision left to a named person.

The demo opens the same synthetic clinic letter.

In practice

A clinician-controlled review, step by step.

One synthetic clinic letter with two kinds of content: a change for a prescriber, and conditional advice, which is flagged for a clinician to review and never treated as an instruction (shown here routed to a GP as a decision: Illustrative).

ReedleyDocument review · Clinic letter · Funmilayo ADEYEMISYNTHETIC

Cardiology outpatients · Northfield General Hospital (fictional)Clinic 30 Sep 2026 · received 4 Oct 2026 08:31 · Funmilayo ADEYEMI · NHS 999 000 0069 · identity matched

¶3 Plan: increase ramipril to 10 mg once daily and recheck renal function in 1–2 weeks.

¶4 Consider stopping amlodipine if ankle swelling persists.

Task lane: a change for a prescriberDecision lane: conditional wording, routed to a GP

01 Identified

4 Oct 2026 · 10:05 · Reedley

Task lane · ¶3 → K. AHMED, clinical pharmacist

Identified

¶3 “increase ramipril to 10 mg once daily and recheck renal function in 1–2 weeks” → a medication change for a prescriber.

Decision lane · ¶4 → Dr S. PATEL, GP

Identified · conditional wording

¶4 “Consider stopping amlodipine if ankle swelling persists.” → conditional wording. Never turned into a medication task.

02 Reviewed by a named clinician

4 Oct 2026 · K. AHMED, clinical pharmacist · Dr S. PATEL, GP

Task lane · ¶3 → K. AHMED, clinical pharmacist

Reviewed · K. AHMED

K. AHMED examines the cited passage beside the record (ramipril 5 mg one daily) and accepts the item.

Decision lane · ¶4 → Dr S. PATEL, GP

Reviewed · Dr S. PATEL

Dr S. PATEL sees ¶4 highlighted, with the record beside it. There is no Accept button on a decision: the GP decides, Reedley records that a decision was made.

Review-level floor. Each kind of work has a minimum review level that practice settings cannot lower, enforced in Reedley’s screens only (no authenticated user yet). draft, awaiting CSO sign-off

03 Assigned

4 Oct 2026 · K. AHMED, clinical pharmacist

Task lane · ¶3 → K. AHMED, clinical pharmacist

Assigned

Owner K. AHMED · prescriber decision required · due: set when the prescriber records the dose decision.

Decision lane · ¶4 → Dr S. PATEL, GP

Routed · awaiting GP decision

Routed to Dr S. PATEL, GP · awaiting GP decision. No owner can be changed to a non-clinician: the review-level floor for a clinical decision is a clinician (draft, awaiting CSO sign-off).

No Accept button. Reedley does not decide whether to stop a medicine.

Review-level floor. Each kind of work has a minimum review level that practice settings cannot lower, enforced in Reedley’s screens only (no authenticated user yet). draft, awaiting CSO sign-off

04 Actioned, then evidenced

4 Oct 2026 15:30 · 7 Oct 2026 16:00 · Dr S. PATEL, GP · Reedley, from the clinical record (Simulated)

Task lane · ¶3 → K. AHMED, clinical pharmacist

Verified 4 Oct 15:30 → Closed · completed

Ramipril 10 mg once daily recorded and issued 4 Oct 15:30 (Simulated). Record shows 10 mg from 4 Oct. Limit: issued is not taken.

Decision lane · ¶4 → Dr S. PATEL, GP

Decision recorded 7 Oct 16:00 → Closed · completed

A decision was recorded by Dr S. PATEL 7 Oct 16:00 (Simulated). Reedley does not show what was decided.

Oversight. Who decided, when, on what evidence: kept in an append-only history. Before 7 Oct 16:00 the lane read “Routed to a clinician · awaiting GP decision”.

Synthetic example · Illustrative concept · not clinical rules · Review floors: draft, awaiting CSO sign-off

No practice uses Reedley yet · Tested on synthetic data only · No EMIS Web or SystmOne integration claimed

Register interestTry the demoThe demo opens the same synthetic clinic letter.

Designed for you

Built around how the work is really done.

Human oversight by design

Every proposal needs a named person; review levels are designed with floors practice settings cannot lower (draft, awaiting CSO sign-off).

Clinical safety approach

A hazard log is maintained with the build; a Clinical Safety Officer will own it before any real-world use.

Explainability

Confidence is shown as a reason a clinician can check, never as a percentage.

Practice-level visibility

What needs attention, where monitoring gaps are, and whether work is being finished.

Proportionate urgency

Urgency comes from authoritative sources, so that “critical” still means something.

Accountability

Decisions belong to named people and are recorded with the evidence used.

Honest status

Where the relevant capabilities stand.

As at 14 November 2026. Nothing here is in use with real patients.

Relevant capabilities and their status
CapabilityStatusBefore real use
Document review with citationsBuilt · synthetic dataAccuracy with a model in the loop not yet measured
My Day worklist and six-state lifecycleBuilt · synthetic dataDevelopment storage only; a production store is planned
Review policy floorsNeeds clinical sign-offNeed Clinical Safety Officer sign-off
Patient Context and What ChangedBuilt · synthetic dataCore platform · intended launch scope · what a clinician needs before opening the record; no real-record evaluation
Ask ReedleyBuilt · synthetic dataCore platform · intended launch scope · record-grounded answers that say when the records are not enough; no clinical advice; accuracy not measured
Clinical risk management (DCB0129)In progressEngineering draft only; no Clinical Safety Officer appointed, so no safety case exists yet
Live clinical-system integrationNeeds supplier approvalNo integration exists or is claimed

The platform pages use three public states for the same facts: “Built · synthetic data” and “Needs clinical sign-off” are in the development build (synthetic data; draft rules unsigned), “In development” is partly built, and every other status here is not built. An illustrative demonstration can show parts that are not built.

Where you would work in the workstation: My Day · Patient Context · Ask Reedley

Not sure where to start? Take the five-question assessment

Questions

What GPs ask us.

More in questions and answers

Does Reedley make clinical decisions?

No. It organises evidence and proposes work. Every decision belongs to a named person in your practice.

What would we need to do before using it with patients?

Your own DCB0160 assessment and a DPIA, supported by Reedley’s clinical safety case report and documentation, plus the relevant supplier approvals. None of that exists yet; it is part of a governed pilot.

Is it NHS-approved?

No. Reedley is independent and is not approved, endorsed or certified by the NHS.

Pilot interest

Help shape Reedley before it is finished.

We are looking for a small number of GP practices and primary care networks to work with us: first on synthetic walkthroughs, then — only with the right approvals, safeguards and agreements — on carefully governed evaluation.

How a pilot would work

  1. 01Register interestA short form. We reply personally to arrange a conversation. No commitment. Or request a demonstration
  2. 02Synthetic walkthroughYour team uses Reedley on synthetic patients and tells us what is wrong with it.
  3. 03Structured feedbackTimed tasks and short interviews, reported honestly, including what did not work.
  4. 04Governed evaluationOnly with a CSO-approved safety case (DCB0129), the practice’s DCB0160, an MHRA device determination, DSPT, a DPIA, a data processing agreement and supplier approvals in place.

Next steps

See it work, share it with your team, then talk to us.

  1. See it work

    A scripted walkthrough of a synthetic clinic letter, from receipt to evidence. Pause or step through it at any point.

    Take the 90-second tour
  2. Share it

    Ten short sections for partners, PCN leads and digital staff, written to be forwarded without a conversation first.

    Read the evaluation pack
  3. Talk to us

    Registering interest takes about a minute. A conversation is with Salim Miah, founder (MPharm, independent prescriber).

Questions buyers ask

What will it cost?

Pricing has not been set. Pilot participation would be agreed individually; we will not ask a practice to pay for something that is not ready.

Who is building Reedley?

Reedley is at an early stage and is currently founder-led. Its founder, Salim Miah MPharm, is a UK-qualified pharmacist and independent prescriber who has worked across community pharmacy, hospital and general practice.

As Reedley grows, clinical safety, engineering and information governance roles will be filled by suitably qualified people, and we will name them here.

How much of our team’s time does a pilot take?

Stage 1 is about an hour; registering interest takes about a minute and applying about five minutes.

Stages 2–4 are agreed with you in the conversation; we will not guess.

Does it work with EMIS Web or SystmOne?

Not today. Reedley is designed around EMIS Web workflows, but no integration exists, none is claimed, and no supplier has approved or partnered with Reedley.

We intend to pursue the published integration routes, such as IM1 pairing, and will report each step on the integration page.

The same applies as for EMIS Web: designed for SystmOne workflows, with no integration existing or claimed.

All questions and answers